Clinical trial
Hyperalgesia and NMDA Receptor Antagonist
NCT02087202 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hyperalgesia and NMDA Receptor Antagonist
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2014
- Completion date
- July 31, 2014
- Enrollment
- 90 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.